Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Endogenous CD4+ T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic KRAS and ERBB2 (Her2) Driver Mutations.

Veatch JR, Jesernig BL, Kargl J, Fitzgibbon M, Lee SM, Baik C, Martins R, Houghton AM, Riddell SR.

Cancer Immunol Res. 2019 Jun;7(6):910-922. doi: 10.1158/2326-6066.CIR-18-0402. Epub 2019 May 1.

PMID:
31043415
2.

Tumor-infiltrating BRAFV600E-specific CD4+ T cells correlated with complete clinical response in melanoma.

Veatch JR, Lee SM, Fitzgibbon M, Chow IT, Jesernig B, Schmitt T, Kong YY, Kargl J, Houghton AM, Thompson JA, McIntosh M, Kwok WW, Riddell SR.

J Clin Invest. 2018 Apr 2;128(4):1563-1568. doi: 10.1172/JCI98689. Epub 2018 Mar 12.

3.

The NCI common toxicity criteria and treatment-associated mortality in acute myeloid leukemia.

Veatch JR, Sandhu V, Becker PS, Pagel JM, Appelbaum FR, Estey E.

Blood. 2013 Jul 11;122(2):293-4. doi: 10.1182/blood-2013-03-492835. No abstract available.

4.

Mitochondrial dysfunction leads to nuclear genome instability via an iron-sulfur cluster defect.

Veatch JR, McMurray MA, Nelson ZW, Gottschling DE.

Cell. 2009 Jun 26;137(7):1247-58. doi: 10.1016/j.cell.2009.04.014.

5.

Ku interacts with telomerase RNA to promote telomere addition at native and broken chromosome ends.

Stellwagen AE, Haimberger ZW, Veatch JR, Gottschling DE.

Genes Dev. 2003 Oct 1;17(19):2384-95. Epub 2003 Sep 15.

Supplemental Content

Loading ...
Support Center